BRANY (Biomedical Research Alliance of New York) has announced it has been designated a Quintiles Prime Site. The designation will advance BRANY’s participation in clinical trials by providing improved access to new industry-sponsored clinical trials.
BRANY joins other select organizations that have received the same designation from Quintiles across the USA, Europe, Africa and Asia. BRANY is committed to excellence in the conduct of clinical research, and the company supports Quintiles’ vision to bring people and knowledge together for a healthier world. BRANY’s network of highly qualified and experienced researchers and track record in working with community and academic study sites will accelerate the development of new therapies.
“BRANY is committed to excellence in clinical research and improving patient care , says Kimberly Irvine, Executive Vice President of Operations at BRANY. “This alliance will provide our leading investigators and hospitals with significant opportunities to access industry-sponsored clinical trials. We are excited to be working with Quintiles to bring new clinical trials to our sites and patients.”
BRANY’s Smart Start 60 increases efficiencies and sustainability among their community and academic study sites to expedite clinical research timelines. These efficiencies translate to real-life benefits as clinical trials are concluded on or ahead of schedule to advance treatments for unmet medical needs in a cost-effective way that does not jeopardize the quality standards of the of research.
“We have been working with BRANY for 14 years and are continuously impressed with the calibre of their investigator network and the quality of their research,” said Lindy Jones, Senior Vice President, Integrated Site Services, Quintiles. “BRANY consistently sets and meets aggressive start-up timelines. They are able to conduct studies in both the hospital and community settingbroadening opportunities for patients to participate in studies. We welcomeBRANY as the newest Prime Site and look forward to continued success together.”
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.